Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Addex Pharmaceuticals S.A.”

3 pharma patents match "Addex Pharmaceuticals S.A." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Addex Pharmaceuticals S.A." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Addex Pharmaceuticals S.A.” · 30,257 patents in full index Clear search

  1. US 11071729

    1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones

    Addex Pharmaceuticals S.A. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  2. US 8399493

    Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors

    Addex Pharmaceuticals S.A. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  3. US 7205411

    Aminopyridine derivatives as mGluR5 antagonists

    Addex Pharmaceuticals S.A. · Granted Apr 17, 2007 · Expires Apr 12, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.